- US100 is trending still above 25,000 pts
- BigTech companies will report earnings in October
- Markets expect that Fed will cut rates by 25 bps this month
- US100 is trending still above 25,000 pts
- BigTech companies will report earnings in October
- Markets expect that Fed will cut rates by 25 bps this month
During the last session of the week, the US100 is attempting to resume its advance, trading 0.12% higher and resisting the narrative around a potential correction in technology stocks as well as uncertainty in the labour market.
- The equity market is entering earnings season, with results from U.S. tech giants due at the end of the month (Microsoft, Meta Platforms, and Alphabet on 29 October; Apple and Amazon on 30 October). As a result, volatility on the Nasdaq may be elevated, and investors will scrutinise the numbers to judge whether the “AI rally” has run ahead of valuations or whether the market’s growth momentum justifies historically elevated multiples.
- Investors will watch not only the upcoming macro data—seeking evidence of ongoing resilience in the U.S. economy—but also trade relations between Beijing and Washington. In Korea, Donald Trump is set to meet with Xi, and recent signals from both countries regarding export restrictions and mutual oversight of businesses appear to be a test of strength aimed at securing a better position ahead of a final trade agreement.
The technical picture for the US100 looks constructive: the index is moving within an upward price channel and is currently “stuck” around the middle of that range near 25,300 points. Key supports are the 50-day EMA (orange line), which defines short-term momentum, and the 200-day EMA (red line), which has acted as support several times in recent weeks. 25,000 points appears to be the key level to hold. A potential Fed rate cut on 29 October would be a positive signal for the US100.
Source: xStation5
BREAKING: USDCAD slips following Canadian employment data 📌
⏫🔝Silver is up 4%
DAX: DE40 tries to hold the momentum 📈Brenntag and ArcelorMittal under pressure
ECB Not Gearing Up for Changes. Is EURUSD Undervalued?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
